Stemmatters is a preclinical stage regenerative medicine company developing innovative medical devices for large unmet medical needs. Stemmatters develops chemically defined, non-animal derived biomaterials for facile delivery and retention of cells into the body. Stemmatters explores a versatile and unique technology platform from which multiple proprietary compounds can be generated with ample freedom to operate. These next generation biomaterials allow the quick development of functional, customized delivery technologies that support the establishment of safer, less costly and more effective solutions for clinical challenges that remain unsolved.
The company’s lead product for cartilage repair offers enhanced therapeutic efficacy and cost effectiveness, bringing unique competitive and regulatory advantages as compared to other devices currently in the market or in late stage clinical development